The electroencephalogram (EEG) and clinical measures of opioid potency: defining the EEG-clinical potency relationship (‘fingerprint’) with application to remifentanil

Authors: TD E.; KT M.; DJ H.; DR S.; SL S.

Source: International Journal of Pharmaceutical Medicine, Volume 15, Number 1, FEBRUARY 2001 , pp. 11-19(9)

Publisher: Adis International

Buy & download fulltext article:

OR

Price: $57.95 plus tax (Refund Policy)

Keywords: opioids; remifentanil; drug development; surrogate measures

Document Type: Research article

Publication date: 2001-02-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page